Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H14ClNO2 |
Molecular Weight | 263.719 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(CC(O)=O)=C(C)N1C2=CC=C(Cl)C=C2
InChI
InChIKey=SJCRQMUYEQHNTC-UHFFFAOYSA-N
InChI=1S/C14H14ClNO2/c1-9-7-11(8-14(17)18)10(2)16(9)13-5-3-12(15)4-6-13/h3-7H,8H2,1-2H3,(H,17,18)
Molecular Formula | C14H14ClNO2 |
Molecular Weight | 263.719 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Clopirac is a non-steroidal anti-inflammatory drug. It is a weak inhibitor of prostaglandin synthetase and has standard anti-inflammatory and analgesic activity. It effectivity inhibits prostaglandin synthesis in vitro. The metabolites of clopirac in humans and monkeys include the glucuronide of clopirac and the pyrrole carboxylic acid. Efficacy of clopirac in rheumatoid arthritis, trauma conditions, osteoarthritis and pain was evaluated in many clinical trials.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Prostaglandin synthetase |
230.0 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1228193 https://www.ncbi.nlm.nih.gov/pubmed/1228200 https://www.ncbi.nlm.nih.gov/pubmed/777001 https://www.ncbi.nlm.nih.gov/pubmed/776999 https://www.ncbi.nlm.nih.gov/pubmed/776987 https://www.ncbi.nlm.nih.gov/pubmed/776986 https://www.ncbi.nlm.nih.gov/pubmed/776985 |
Palliative | Unknown Approved UseUnknown |
||
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
[Double-blind study of indomethacin and CP 172 AP (clopirac) in lombarthrosis (author's transl)]. | 1975 |
|
[Open trial for the evaluation of the therapeutic effectiveness of i-p chlorophenyl-2,5-dimethyl-3-pyrrole acetic acid (clopirac) in rheumatoid arthritis (author's transl)]. | 1975 |
|
Double-blind cross-over study of clopirac and naproxen in rheumatoid arthritis. | 1975 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12259
Rat: 150 mg/kg
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12259
The ability of clopirac to inhibit the conversion of [3H]arachidonic acid into PGE, was measured in a microsomal enzyme preparation isolated from bovine seminal vesicles. The defined IC50 value was about 45 uM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:26:31 GMT 2023
by
admin
on
Fri Dec 15 16:26:31 GMT 2023
|
Record UNII |
J23127WJYB
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 16:26:31 GMT 2023 , Edited by admin on Fri Dec 15 16:26:31 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID9046158
Created by
admin on Fri Dec 15 16:26:31 GMT 2023 , Edited by admin on Fri Dec 15 16:26:31 GMT 2023
|
PRIMARY | |||
|
100000083999
Created by
admin on Fri Dec 15 16:26:31 GMT 2023 , Edited by admin on Fri Dec 15 16:26:31 GMT 2023
|
PRIMARY | |||
|
255-938-5
Created by
admin on Fri Dec 15 16:26:31 GMT 2023 , Edited by admin on Fri Dec 15 16:26:31 GMT 2023
|
PRIMARY | |||
|
3718
Created by
admin on Fri Dec 15 16:26:31 GMT 2023 , Edited by admin on Fri Dec 15 16:26:31 GMT 2023
|
PRIMARY | |||
|
C65341
Created by
admin on Fri Dec 15 16:26:31 GMT 2023 , Edited by admin on Fri Dec 15 16:26:31 GMT 2023
|
PRIMARY | |||
|
3453
Created by
admin on Fri Dec 15 16:26:31 GMT 2023 , Edited by admin on Fri Dec 15 16:26:31 GMT 2023
|
PRIMARY | |||
|
SUB06742MIG
Created by
admin on Fri Dec 15 16:26:31 GMT 2023 , Edited by admin on Fri Dec 15 16:26:31 GMT 2023
|
PRIMARY | |||
|
42779-82-8
Created by
admin on Fri Dec 15 16:26:31 GMT 2023 , Edited by admin on Fri Dec 15 16:26:31 GMT 2023
|
PRIMARY | |||
|
CHEMBL1718918
Created by
admin on Fri Dec 15 16:26:31 GMT 2023 , Edited by admin on Fri Dec 15 16:26:31 GMT 2023
|
PRIMARY | |||
|
J23127WJYB
Created by
admin on Fri Dec 15 16:26:31 GMT 2023 , Edited by admin on Fri Dec 15 16:26:31 GMT 2023
|
PRIMARY | |||
|
39299
Created by
admin on Fri Dec 15 16:26:31 GMT 2023 , Edited by admin on Fri Dec 15 16:26:31 GMT 2023
|
PRIMARY | |||
|
m661
Created by
admin on Fri Dec 15 16:26:31 GMT 2023 , Edited by admin on Fri Dec 15 16:26:31 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |